Thomas Dörner is a board certified Rheumatologist and Clinical Immunologist as well as Transfusion Medicine and Hemostaseology. He is Professor of Rheumatology and Clinical Immunology for Innovative Therapies at Charite University Hospitals Berlin, Germany and group leader of the B cell memory group at the German Research Center of Rheumatology Berlin. He qualified in Medicine in 1990 at Charite University Hospitals Berlin and received his board certification in internal medicine in 1995 before undertaking a post-doctoral fellowship at the University of Texas, Southwestern Medical Center at Dallas, where he researched delineating molecular aspects of the B cell receptor gene usage in autoimmune diseases.

Currently he has a professorship for Innovative therapeutics in Autoimmune Diseases at Charité Universitätsmedizin Berlin. His current main research topics comprise translational projects in autoimmune diseases with a main focus on the role of cytokines and B cells, the interrelationship of coagulation during immune activation and searching for biomarkers of therapeutic responses.

Professor Dörner has received a number of international and national awards, including the Senior Scholar Award of the American Society of Rheumatology, the H Schultze Award of the German League against Rheumatism, the Schoen Award of the German Society of Rheumatology and the Fischer Prize by the NIH.

Professor Dörner has served as a member of editorial boards of leading journals in rheumatology, including Arthritis & Rheumatism, Arthritis Research & Therapy, Annals of the Rheumatic Diseases, Lupus Science and Medicine, Global Arthritis Research Network (GARN), Current Reviews in Rheumatology, Brazilian Journal of Rheumatology, Rheumatology Reviews, European Journal of Immunology and Zeitschrift für Rheumatologie.